These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11789307)

  • 21. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men.
    Kahn J
    Clin Infect Dis; 2002 Dec; 35(11):1382-7. PubMed ID: 12439802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A and B booster recommendations: implications for travelers.
    Zuckerman JN; Connor BA; von Sonnenburg F
    Clin Infect Dis; 2005 Oct; 41(7):1020-6. PubMed ID: 16142669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis A and B immunization for individuals with inherited bleeding disorders.
    Steele M; Cochrane A; Wakefield C; Stain AM; Ling S; Blanchette V; Gold R; Ford-Jones L
    Haemophilia; 2009 Mar; 15(2):437-47. PubMed ID: 19335752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes.
    Spence L; Brown WJ; Pyne DB; Nissen MD; Sloots TP; McCormack JG; Locke AS; Fricker PA
    Med Sci Sports Exerc; 2007 Apr; 39(4):577-86. PubMed ID: 17414793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of sports medicine physicians regarding psychological issues in patient-athletes.
    Mann BJ; Grana WA; Indelicato PA; O'Neill DF; George SZ
    Am J Sports Med; 2007 Dec; 35(12):2140-7. PubMed ID: 17641103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway inflammation and upper respiratory tract infection in athletes: is there a link?
    Bermon S
    Exerc Immunol Rev; 2007; 13():6-14. PubMed ID: 18198657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity and immunizations.
    Palenik CJ; Govoni M
    Dent Today; 2004 Jan; 23(1):100-3. PubMed ID: 14969005
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis vaccination and prophylaxis.
    Nguyen CT; Tran TT
    Clin Liver Dis; 2009 May; 13(2):317-29. PubMed ID: 19442921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
    Hernandez B; Hasson NK; Cheung R
    Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations.
    Isaguliants MG
    Expert Rev Vaccines; 2007 Aug; 6(4):527-37. PubMed ID: 17669007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events after hepatitis A B combination vaccine.
    Woo EJ; Miller NB; Ball R;
    Vaccine; 2006 Mar; 24(14):2685-91. PubMed ID: 16310295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization programs in non-traditional settings.
    Weatherill SA; Buxton JA; Daly PC
    Can J Public Health; 2004; 95(2):133-7. PubMed ID: 15074905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.